Relation of Decongestion and Time to Diuretics to Biomarker Changes and Outcomes in Acute Heart Failure
Open Access
- 1 May 2021
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 147, 70-79
Abstract
No abstract availableKeywords
Funding Information
- Abbott Laboratories
This publication has 28 references indexed in Scilit:
- B-Type Natriuretic Peptide Trend Predicts Clinical Significance of Worsening Renal Function in Acute Heart FailureEuropean Journal of Heart Failure, 2019
- The Effect of Door-to-Diuretic Time on Clinical Outcomes in Patients With Acute Heart FailureJACC: Heart Failure, 2018
- Time-to-Furosemide Treatment and Mortality in Patients Hospitalized With Acute Heart FailureJACC, 2017
- Neutrophil Gelatinase-Associated Lipocalin for Acute Kidney Injury During Acute Heart Failure HospitalizationsJACC, 2016
- A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ÉLAN-HF ScoreHeart, 2013
- Early intravenous heart failure therapy and outcomes among older patients hospitalized for acute decompensated heart failure: Findings from the Acute Decompensated Heart Failure Registry Emergency Module (ADHERE-EM)American Heart Journal, 2013
- Timing of Immunoreactive B-Type Natriuretic Peptide Levels and Treatment Delay in Acute Decompensated Heart FailureJACC, 2008
- Natriuretic PeptidesJACC, 2007
- NT-ProBNP Reduction Percentage During Admission for Acutely Decompensated Heart Failure Predicts Long-Term Cardiovascular MortalityJournal of Cardiac Failure, 2005
- N-Terminal–Pro-Brain Natriuretic Peptide Predicts Outcome After Hospital Discharge in Heart Failure PatientsCirculation, 2004